How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort-Reference-Cited by-同舟云学术

How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort

Published:2018-10-25 Issue:1 Volume:26 Page:109-117
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Pietrasz Daniel,Turrini Olivier,Vendrely Véronique,Simon Jean-Marc,Hentic Olivia,Coriat Romain,Portales Fabienne,Le Roy Bertrand,Taieb Julien,Regenet Nicolas,Goere Diane,Artru Pascal,Vaillant Jean-Christophe,Huguet Florence,Laurent Christophe,Sauvanet Alain,Delpero Jean-Robert,Bachet Jean Baptiste,Sa Cunha Antonio

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-018-6931-6/fulltext.html

Reference28 articles.

1. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma. J Natl Compr Cancer Netw JNCCN. 2017;15(8):1028–61.

2. Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2–11.

3. Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6):2403–13.

4. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25.

5. Christians KK, Tsai S, Mahmoud A, et al. Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? Oncologist. 2014;19(3):266–74.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally Advanced Pancreas Cancer, Is There a Role for Surgery?;Surgical Clinics of North America;2024-10

2. Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.;Pancreatology;2024-09

3. Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma;Annals of Surgery Open;2024-09

4. Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?;Cancers;2024-06-30

5. The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma;The American Surgeon™;2024-04-18